Gregor Tevz

Gregor Tevz is a skilled genomic scientist currently employed at Sequins since May 2023, following a notable tenure at SpeeDx Pty Ltd as a Senior Research Scientist. Expertise spans across multiple companies, including roles in senior product development and research, with significant contributions to prostate cancer translational research while leading a subtheme in an international Movember Revolutionary Team. Gregor's research background encompasses cancer gene therapies, biomarker discovery, and drug development, complemented by extensive training and secondments in prestigious institutions. Academic qualifications include a PhD in Biomedicine and a BSc in Microbiology from the University of Ljubljana, along with a strong proficiency in various molecular and imaging techniques.